TABLE 1.

Correlation of serum HBV DNA, HDV RNA, and HBsAg levels and age with disease courses

Patient group, no. (sex), and age (yr)	HBV type	HDV type	Outcome	ALT (U/liter)	ASTa (U/liter)	HBV DNA (copies/ml)	HBsAg (IU/ml)	HDV RNA (copies/ml)
Disease remission
I (M)
50b	B	1	CHD	360	176	19,200	184.2	36,320
51c			CHD	128	48	38,700	118.6	552,253
53d			CHD	295	129	346,000	631.3	10,882,490
56			Remission	41	28	<300	0.1	<400
66			Remission	20	16	<300	0	<400
II (M)
28c	B	2	CHD	107	80	<300	2670	82,200,000
40d			CHD	129	76	<300	1831.6	19,800
42			Remission	14	21	<300	0.1	<400
43			Remission	33	21	<300	0	<400
III (M)
33c	NDe	4	AHDf	1,235	645	<300	6,458	32,200,000
44d			CHD	61	55	<300	3,643	2,05,200
50			Remission	16	23	<300	0.1	<400
61			Remission	21	23	<300	0.1	<400
IV (M)
27c	B	4	AHD	926	502	987	784	2,755,440
29d			CHD	117	83	<300	138.4	185,884
44			Remission	14	19	<300	0.2	<400
45			Remission	22	23	<300	0.2	<400
Disease progressiong
V (F)
24c	C	4	CHD	179	153	14,900	11,456	303,200,000
29d			CHD	79	62	189,800	7,825	89,600,000
33			CHD	56	48	66,348	9,875.2	29,300,000
VI (M)
48c	B	1	Cirrhosis	32	26	<300	945.4	4,076,000
53d			Cirrhosis	44	36	<300	829.2	1,064,000
56			Cirrhosis	17	16	<300	542.1	3,236
63			Cirrhosis	25	19	1,164	77.8	<400
67			Cirrhosis	22	20	<300	73.8	<400
VII (F)
52c	B	4	HCC	41	23	<300	309.6	840,000
56d			HCC	45	41	2,060	841.5	1,968,560
58			HCC	55	50	3,270	1,372	1,138,134

^aAST, aspartate transaminase.

^bFirst time point.

^cEarly time point.

^dLate time point.

^eND, nondetectable.

^fAHD, acute hepatitis D.

^gWith persistently elevated ALT or adverse outcomes (cirrhosis or HCC).